WASHINGTON, May 24, 2016 /PRNewswire-USNewswire/ -- As the independent drugstore lobby descends on Capitol Hill this
"PBMs will save consumers, employers, unions, and government programs $654 billion over the next decade," said PCMA President and CEO Mark Merritt. "Unfortunately, the independent drugstore lobby agenda would raise costs for seniors, employers, and programs like Medicare Part D."
PBMs reduce drug costs by:
Click here to learn more about PCMA's That's What PBMs Do campaign.
The independent drugstore lobby wants Congress to pursue so-called "Any Willing Pharmacy" mandates (H.R. 793/S. 1190) that would eliminate the popular "preferred pharmacy" plans in Medicare. These mandates would increase spending by $21 billion over 10 years, according to research from The Moran Company examining the same legislation introduced previously.
Research and polling highlight the value of preferred pharmacies in Medicare, including:
Another drugstore lobby mandate (HR 244) would gut a key cost-control tool—the use of Maximum Allowable Cost (MAC) lists—which ensure payers aren't overpaying pharmacies for generic drugs. Forty-five state Medicaid programs now use MAC lists to reduce costs.
The Health and Human Services Office of Inspector General (OIG) touted "the significant value MAC programs have in containing Medicaid drug costs." The OIG also recommended that states strengthen MAC programs, not weaken them. Likewise, a white paper authored by David Hyman, a former Special Counsel at the FTC, notes that "legislative or regulatory measures that limit, restrict, or interfere with MACs are likely to have several unintended adverse consequences," including higher prices and tacit collusion among pharmacies.
The independent drugstore lobby also opposes patient safety legislation to curb prescription drug abuse in Medicare, known as "Safe Pharmacy" or "Lock-In." Creating this program in Part D for controlled substances would allow health plans to require at-risk beneficiaries to work with their plans to choose a single pharmacy to dispense controlled substances.
The independent drugstore lobby's argument for new mandates is undermined by their own research. According to a Drug Channels analysis of the 2015 National Community Pharmacists Association (NCPA) Digest, the number of independent pharmacies continues to hold steady and profit margins remain stable.
PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-independent-drugstore-lobby-agenda-higher-drug-prices-fewer-choices-in-medicare-300273884.html
SOURCE Pharmaceutical Care Management Association
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All